NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders

AO Egunlusi, J Joubert - Pharmaceuticals, 2024 - mdpi.com
Neurodegenerative disorders (NDs) include a range of chronic conditions characterized by
progressive neuronal loss, leading to cognitive, motor, and behavioral impairments …

Molecular mechanism of ligand gating and opening of NMDA receptor

TH Chou, M Epstein, RG Fritzemeier, NS Akins… - Nature, 2024 - nature.com
Glutamate transmission and activation of ionotropic glutamate receptors are the fundamental
means by which neurons control their excitability and neuroplasticity. The N-methyl-d …

[HTML][HTML] Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative …

M Nakashima, N Suga, S Yoshikawa, S Matsuda - Molecules, 2024 - mdpi.com
Some neurodegenerative diseases may be characterized by continuing behavioral and
cognitive dysfunction that encompasses memory loss and/or apathy. Alzheimer's disease is …

[HTML][HTML] Glucose-6-phosphate dehydrogenase alleviates epileptic seizures by repressing reactive oxygen species production to promote signal transducer and …

L Hu, Y Liu, Z Yuan, H Guo, R Duan, P Ke, Y Meng… - Redox Biology, 2024 - Elsevier
The pathogenesis of epilepsy remains unclear; however, a prevailing hypothesis suggests
that the primary underlying cause is an imbalance between neuronal excitability and …

Investigation of metal ion binding biomolecules one molecule at a time

M de la Torre, A Pomorski - Frontiers in Chemistry, 2024 - frontiersin.org
Metal ions can perform multiple roles ranging from regulatory to structural and are crucial for
cell function. While some metal ions like Na+ are ubiquitously present at high …

[HTML][HTML] Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine–Glutamate …

L Raiteri - Biomedicines, 2024 - mdpi.com
Glycine plays a pivotal role in the Central Nervous System (CNS), being a major inhibitory
neurotransmitter as well as a co-agonist of Glutamate at excitatory NMDA receptors …

Efficacy of GluN2B-Containing NMDA receptor antagonist for antitumor and antidepressant therapy in non-small cell lung cancer

W Bian, Y Chen, Y Ni, B Lv, B Gong, K Zhu… - European Journal of …, 2024 - Elsevier
Non-small cell lung cancer (NSCLC) is the predominant subtype of lung cancer. Evidence
suggests that the ionotropic glutamate receptor N-methyl-D-aspartate (NMDA) receptor, a …

Role of Astrocytes in Alzheimer's Disease Pathogenesis and the Impact of Exercise-induced Remodeling

J Shao, Q Deng, S Feng, C Wu, X Liu, L Yang - … and Biophysical Research …, 2024 - Elsevier
Alzheimer's disease (AD) is a prevalent and debilitating brain disorder that worsens
progressively with age, characterized by cognitive decline and memory impairment. The …

[PDF][PDF] Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.

M Korinek, MC Serra, FES ABDEL RAHMAN… - Physiological …, 2024 - biomed.cas.cz
N-methyl-D-aspartate receptors (NMDARs) are a subtype of ionotropic glutamate receptors
critical for synaptic transmission and plasticity, and for the development of neural circuits …

Neuronal ARHGAP8 controls synapse structure and AMPA receptor-mediated synaptic transmission

J Schmidt, Â Inácio, JS Ferreira, D Serrenho… - bioRxiv, 2024 - biorxiv.org
The aberrant formation and function of neuronal synapses are recognized as major
phenotypes in many cases of neurodevelopmental (NDDs) and-psychiatric disorders …